Alphagan : Patient Homepage

How is glaucoma treated?

In patients with glaucoma, reducing elevated IOP is the only treatable risk factor to prevent vision loss. The most common treatment to reduce elevated IOP is medication in the form of eyedrops like ALPHAGAN^® P. These medications decrease IOP, either by reducing the production of aqueous humor within the eye or by increasing the drainage of it from the eye. Laser treatment or even surgery may be needed when medical treatment alone is insufficient.

ALPHAGAN^® P ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

Important Safety Information
ALPHAGAN^® P (brimonidine tartrate ophthalmic solution) 0.1% should not be used in patients receiving monoamine oxidase (MAO) inhibitor therapy. Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, ocular redness, and itching. Adverse events occurring in approximately 5% to 9% included: burning sensation, increased ocular lymph nodules, increased ocular pressure, ocular allergic reaction, dry mouth, and blurred vision.

Please click here for full Prescribing Information.